NHS Research Scotland - Overview Dr Alison Walker National Coordinator, NRS Permissions CC

Slides:



Advertisements
Similar presentations
The NIHR Clinical Research Network supports research to make patients, and the NHS, better Carrying out Research at Milton Keynes Hospital NHS Foundation.
Advertisements

Research Within The NHS Prof Alison MacLeod Director Research & Development.
Research Policy & Management RACD INTRODUCTION TO RESEARCH GOVERNANCE.
UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
New Trials If you are seeking a collaboration with the UCL CCTU we require you to apply: At least 3 months before the application deadline By using the.
Applying for additional funding for eligible* activity in CRN: Kent, Surrey and Sussex Applicant* Trust R&D for authorisation ( encouraged) Relevant.
Working together for better Research - Collaborative research with BCUHB Dr Nefyn Williams & Dr Richard Tranter, NWORTH Associate Clinical Directors &
Northern Ireland Clinical Research Networks Judy Bradley PhD MCSP Reader in Physiotherapy Joint Clinical Lead NICRN (Respiratory Health)
Administrative Data Research Centre for England 1.
“Best Research for Best Health” Andrew Riley Managing Director.
Navigating the Networks Chantal Sunter July 2014.
West Midlands (North) Comprehensive Local Research Network Streamlining Research Management and Governance Arrangements Single Assessment Service & Research.
Managing the Performance of Homecare Medicines Services Jane Kelly, Procurement Project Pharmacist Mick Butterfield, Specialist Technician: Homecare Medicines.
NHS Research Scotland -Overview -Feasibility -R&D permissions Dr Alison Walker National Coordinator, NRS Permissions CC Commercial presentation.
AcoRD Implementation Amber O’Malley, CRN Funding and Contracts Manager & AcoRD Business Lead.
Janet Darbyshire (25 June 07) UK Clinical Research Network (UKCRN) Identifying research priorities in the UK Clinical Research Network.
November 10, Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.
Local Planners and Modernisation Networks Judith McGregor Head of Programmes Skills for Health Academy North West.
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) A single system for processing and reviewing applications.
Improving Clinical Research across the UK – Who, Why, How? Matthew Hallsworth, Communications Programme Manager Marianne Miles, Patient and Public Involvement.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction.
Research and Development 07/05/2015 Bala Thirugnanabalan & Dale Batham.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
Michael Bowdery Interim Head of NISCHR
The NIHR Stroke Research Network Supporting research to make patients, and the NHS, better The NIHR Stroke Research Network Judith Williamson and Zena.
Dr David Jackson Clinical Lead for Research YCRN Co-director WYCLRN Yorkshire Palliative Medicine Regional Learning Group April 2008 Clinical Research.
SMC Horizon Scanning Anne Lee, Scottish Medicines Consortium Julia Earnshaw, GlaxoSmithKline.
The Role of the Research Office Joint Research & Enterprise Office (JREO) St George’s University of London and St George’s University Hospitals NHS Foundation.
How to contact us Scottish Mental Health Research Network “Facilitating the development, set up and successful completion of mental health research studies.
Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a’r Fro NHS R&D Overview How to avoid the common pitfalls? Thomas Fairman Research Liaison Manager.
A Sense of Connection Managed Knowledge Networks and You Dr Ann Wales NHS Education for Scotland.
R&D – a perspective Dr Nana Theodorou Research Coordinator Sheffield Clinical Research Office.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
PHE Local Intelligence Contribution David Meechan, Director for Knowledge & Intelligence (East Midlands), Public Health England.
Accessing the NHS for Research – NHS R&D Permissions Jemma Hughes R&D Manager ABMU Health Board.
A Sense of Connection Managed Knowledge Networks and You.
R&I LEADS - ESSENTIAL DUTIES Attend the Trust R&I Forum. Encourage participation in NIHR Portfolio Research. NEW Work with R&I to ensure the Trust meets.
Change to the Permissions process for Clinical Research Health Research Authority & UCLH Response UCL/UCLH Joint Research Office 2015/16.
Update – April 2015 Champions for Research Support Meeting Delivering research to make patients, and the NHS, better.
© 2016 University at Buffalo Click Training Agreements Module University at Buffalo Office of the Vice President for Research and Economic Development.
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Diabetes Research Network Professor Azeem Majeed Imperial College, London.
London (South) Comprehensive Local Research Network
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction
Engaging and Supporting Surgical Research: Clinical Research Networks
Eligibility Process for Cohort 4 & 5 HRA Approval Studies (post CSP) RM&G Lead’s 09 March 2015 Louise Lambert: Non-commercial Research Initiatives.
The Essentia Institute of Rural Health (EIRH) is
PERMISSIONS COORDINATING CENTRE
SWAG SSG Brain Meeting Wednesday 16th November 2016
Dr Richard Weller. NHS Research Scotland (NRS) Dermatology Lead
The Role of the Oral Dental Specialty Group
PERMISSIONS COORDINATING CENTRE
R&D Permissions Process (multicentre)
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction
ACCORD Update/Training Event The Changing Research Landscape 26th February 2019 Heather Charles Head of Research Governance.
Network support for researchers Jonathan Sheffield, Chief Executive
UK-wide study: (lead R&D office in other UK nation) (Non-commercial)
ACCORD UPDATE EVENTS 2019 Sponsorship and R&D
UK-wide study (lead R&D office in Scotland)
Process: Scotland only study (multicentre)
Health Service R&D permissions
ACCORD Update Event Fiona McArdle Deputy R&D Director Wellcome Auditorium Queen’s Medical Research Institute 26th February 2019.
NRS R&D permissions process Scottish sites only, multicentre
UK Wide Working Mary Cubitt Programme Implementation Manager
UK-wide study (lead R&D office in other UK nation)
NRS R&D permissions process Scottish sites only, multicentre
Presentation transcript:

NHS Research Scotland - Overview Dr Alison Walker National Coordinator, NRS Permissions CC

Agenda Background to NRS / NRS Permissions CC Feasibility service NHS R&D permissions process for Scotland NRS Metrics Progress/future plans

NHS Research Scotland Collaboration –CSO –14 NHS Boards in Scotland Funding –CSO and Scottish Enterprise Function –coordinate R&D processes and systems ‘..agree and implement national policy to deliver greater efficiency in the NHS R&D and Research Ethics function’ More efficient and effective service for industry CSO – Chief Scientist office

Hub & Spoke Model Four regional hubs – NRS North (NHS Grampian) NRS Permissions CC – NRS South West (NHS GG&C) IT systems lead (SReDA) – NRS South East (NHS Lothian) Contracts National training – NRS East (NHS Tayside) Governance Regional arrangements deliver co-ordinated systems to facilitate clinical research GG&C – Greater Glasgow & Clyde

NRS Permissions CC Dedicated administrative team Single point of contact Feasibility service Coordinate study set-up Link with other UK-coordinated systems: –CSP Unit (England) –NISCHR PCU (Wales) –Northern Ireland Gateway Streamlined process to obtain R&D permission for multicentre research in Scotland

NRS Permissions CC - the team Director – Professor David Reid National Co-ordinator – Dr Alison Walker Senior Administrators – Pamela Shand – Karen Innes Administrator – Lindsay Grant

NRS Permissions CC - Services Coordination of study start-up processes –Master CDAs –Feasibility across Scotland –R&D permissions process for multicentre 1 studies Coordination of post-approval processes –Amendments –Addition of new sites CDA – Confidentiality Disclosure Agreements 1 ≥ one site in UK

Feasibility in Scotland Protocol/Questionnaire received by NRS Permissions CC Commercial R&D Managers & Facilitators Scottish Topic-specific Network Managers Scottish Clinical Speciality Leads Specialist Investigators Collated feedback to Sponsor Process actively managed with an aim to feedback within 2 weeks

Key Therapy Areas Cardiovascular Disease Gastrointestinal Disease Inflammation/Immunology Neuroscience Ophthalmology Respiratory Disease Tissue Research Dermatology Infectious Disease Metabolic Disease/Diabetes Oncology Mental Health Stroke Women’s Health Extensive imaging infrastructure and latest biomedical NMR imaging techniques Scottish Clinical Specialty Lead represented on UKCRN/NIHR Specialty Groups Topic-Specific Research Networks e.g. Diabetes, Mental Health, Dementia, Cancer, Stroke, Medicines for Children, Primary Care

Coordinated R&D Permissions

Process Overview Processes run in parallel 30 calendar days from ‘full document set’ to R&D permission Initial approach to NRS Permissions CC ‘Full document set’ received by NRS Permissions CC Lead Health BoardLocal Health Board Certificate of Compliance Generic Review Management Approval Local Review

When to submit to NRS Permissions CC R&D permission process in Scotland is simple, but can vary depending on:- –single- or multicentre in Scotland? –UK-wide study involving CSP, etc? –lead R&D office? When to submit via NRS Permissions CC –More than one Board/Trust within UK Regardless of adoption in England Regardless of use of CSP, etc.

Lead R&D Office in Scotland NRS Permissions CC: –collates the global document set –forwards IRAS R&D Form plus global document set, promptly, to other UK Coordinating Centres –assigns a Lead reviewer in Scotland to carry out a generic review on behalf of the UK –forwards the Certificate of Compliance (CofC) to other UK nations Scottish Boards and UK Trusts/Boards complete local reviews

UK Wide Study – Lead from Scotland Permissions CC will confirm when we have a full document set Applicant notifies Permissions CC of UK-wide multicentre project Permissions CC sends applicant ‘Document Submission Checklist’ Applicant sends IRAS R&D application to Permissions CC; and IRAS SSI Forms to PIs (UK-wide) Confidentiality Agreements as required Permissions CC uploads documents to SReDA; notifies participating Scottish R&D office(s); requests outstanding documents; assigns lead reviewer Generic ReviewLocal Review(s) Scottish sites Permissions CC s IRAS R&D Form to other UK nation(s) Certificate of Compliance (CofC) For each Scottish Health Board: Local management permission letter Permissions CC s CofC to other UK nation(s) Permissions CC s global documents to other UK nation(s) SSI Form

R&D Application Submission documents to Confirm participating Health Boards/sites Submit prior to Ethics/MHRA approval IRAS SSI Form sent to local Investigators (PI), for completion, signing and submission to local R&D office For commercially-sponsored projects: UK CRN Industry Costing Template current version Scottish model contract –mCTA, mCIA, mCTA-CRO, mCIA-CRO, mRegistry/Epidemiology

Scotland’s performance

NRS Performance Metrics Non-commercial studies: R&D permission times (Jan 10 – Dec 12)

Commercial Statistics Commercial clients to date: –134 Pharmaceutical / Device companies – 49 Contract Research Organisations Total number of commercial projects : 441 –67% using only a single site in Scotland Feasibilities (commercial) –224 coordinated

NRS Performance Metrics Commercial studies: R&D permission times (Jan 10 – Dec 12)

Commercial Feedback “Time to approval accurate and simple advice on how to submit; R&D accepted NIHR budget with no questions (a very refreshing change!). Very quick, straightforward and reliable (it’s the submission I don’t have to worry about!). ” “Process was smooth from start to finish. Scottish site was first site to be granted R&D approval, 7 days before second R&D approval at English site.” “R&D communication and approval process. Excellent, in fact, encouraging to Sponsors to perform more studies in Scotland.” No. of replies = 84UnacceptablePoorAcceptableGoodExcellent Availability of NRS PCC personnel? Competence of NRS PCC personnel? Helpfulness/attitude/ flexibility of NRS PCC? Overall experience?

Progress and moving forward

Progress to date Consistent R&D permission times Single commercial price for Scotland Patient Recruitment –Management systems to monitor recruitment –SHARE – patient database Re-branding Website ( –Board capability statements Engagement with Industry –NHS/Industry partnership forum –Visits and presentations

Moving forward Engagement –Industry Liaison Manager Health informatics –Safe havens Website development –Enhanced capability statements –Commonly requested documents Lab certificates CVs ?? Commercial prices Recruitment –Active management

Supporting Studies Locally Commercial Facilitators – 2 in each node (primary and secondary care) – Assist with feasibility, start up and recruitment Nurses –Dedicated research nurses –Expert support for investigators Imaging infrastructure –Dedicated scanners and reporting

Contact Details Dr Alison Walker National Coordinator NHS Research Scotland Permissions Coordinating Centre (NRS Permissions CC) Tel: NRS Permissions CC Office Tel: Website: